<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39452234</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2079-6382</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>14</Day></PubDate></JournalIssue><Title>Antibiotics (Basel, Switzerland)</Title><ISOAbbreviation>Antibiotics (Basel)</ISOAbbreviation></Journal><ArticleTitle>A Machine Learning Approach to Determine Risk Factors for Respiratory Bacterial/Fungal Coinfection in Critically Ill Patients with Influenza and SARS-CoV-2 Infection: A Spanish Perspective.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">968</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/antibiotics13100968</ELocationID><Abstract><AbstractText><b>Background</b>: Bacterial/fungal coinfections (COIs) are associated with antibiotic overuse, poor outcomes such as prolonged ICU stay, and increased mortality. Our aim was to develop machine learning-based predictive models to identify respiratory bacterial or fungal coinfections upon ICU admission. <b>Methods</b>: We conducted a secondary analysis of two prospective multicenter cohort studies with confirmed influenza A (H1N1)pdm09 and COVID-19. Multiple logistic regression (MLR) and random forest (RF) were used to identify factors associated with BFC in the overall population and in each subgroup (influenza and COVID-19). The performance of these models was assessed by the area under the ROC curve (AUC) and out-of-bag (OOB) methods for MLR and RF, respectively. <b>Results</b>: Of the 8902 patients, 41.6% had influenza and 58.4% had SARS-CoV-2 infection. The median age was 60 years, 66% were male, and the crude ICU mortality was 25%. BFC was observed in 14.2% of patients. Overall, the predictive models showed modest performances, with an AUC of 0.68 (MLR) and OOB 36.9% (RF). Specific models did not show improved performance. However, age, procalcitonin, CRP, APACHE II, SOFA, and shock were factors associated with BFC in most models. <b>Conclusions</b>: Machine learning models do not adequately predict the presence of co-infection in critically ill patients with pandemic virus infection. However, the presence of factors such as advanced age, elevated procalcitonin or CPR, and high severity of illness should alert clinicians to the need to rule out this complication on admission to the ICU.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rodríguez</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8828-5984</Identifier><AffiliationInfo><Affiliation>Critical Care Department, Hospital Universitari Joan XXIII, 43005 Tarragona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Universitat Rovira &amp; Virgili, 43005 Tarragona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pere Virgili Health Research Institute, 43005 Tarragona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biomedical Research Network Respiratory Diseases (CIBERES), 43005 Tarragona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gómez</LastName><ForeName>Josep</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Universitat Rovira &amp; Virgili, 43005 Tarragona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Technical Secretary's Department, Hospital Universitari Joan XXIII, 43005 Tarragona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martín-Loeches</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-5834-4063</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Multidisciplinary Intensive Care Research Organization (MICRO), St James' Hospita, D08 NHY1 Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Claverias</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Critical Care Department, Hospital Universitari Joan XXIII, 43005 Tarragona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pere Virgili Health Research Institute, 43005 Tarragona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Díaz</LastName><ForeName>Emili</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-3637-3821</Identifier><AffiliationInfo><Affiliation>Critical Care Department, Hospital Universitari Parc Tauli, 08208 Sabadell, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medicine Faculty, Universitat Autónoma de Barcelona, 08193 Sabadell, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaragoza</LastName><ForeName>Rafael</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-6593-5486</Identifier><AffiliationInfo><Affiliation>Critical Care Department, Hospital Dr. Peset, 46017 Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borges-Sa</LastName><ForeName>Marcio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Critical Care Department, Hospital Son Llatzer, 07198 Palma de Mallorca, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gómez-Bertomeu</LastName><ForeName>Frederic</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Universitat Rovira &amp; Virgili, 43005 Tarragona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pere Virgili Health Research Institute, 43005 Tarragona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Microbiology/Clinical Analysis Laboratory, Hospital Universitari de Tarragona Joan XXIII, 43005 Tarragona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Research in Infectious Diseases Network (CIBERINFEC), 28220 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franquet</LastName><ForeName>Álvaro</ForeName><Initials>Á</Initials><Identifier Source="ORCID">0000-0003-1976-3641</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, Universitat Rovira &amp; Virgili, 43005 Tarragona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Technical Secretary's Department, Hospital Universitari Joan XXIII, 43005 Tarragona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trefler</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Critical Care Department, Hospital Universitari Joan XXIII, 43005 Tarragona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pere Virgili Health Research Institute, 43005 Tarragona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>González Garzón</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Postgrado Medicina Crítica y Cuidado Intensivo, Facultad de Medicina, Fundación Universitari Ciencias de la Salud, Distrito Especial, Cra. 54 No.67A-80, Bogotá 111221, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cortés</LastName><ForeName>Lissett</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Postgrado Medicina Crítica y Cuidado Intensivo, Facultad de Medicina, Fundación Universitari Ciencias de la Salud, Distrito Especial, Cra. 54 No.67A-80, Bogotá 111221, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alés</LastName><ForeName>Florencia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Internal Medicine Department, Hospital Dr. Alejandro Gutiérrez, Venado Tuerto S2600, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sancho</LastName><ForeName>Susana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Critical Care Department, Hospital Universitrio y Politécnico La Fe, 46026 Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solé-Violán</LastName><ForeName>Jordi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Critical Care Department, Hospital Dr. Negrin, 35010 Las Palmas de Gran Canaria, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Estella</LastName><ForeName>Ángel</ForeName><Initials>Á</Initials><Identifier Source="ORCID">0000-0003-0665-557X</Identifier><AffiliationInfo><Affiliation>Critical Care Department, University Hospital of Jerez, INIBiCA, 11407 Jerez, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Cádiz, 11407 Jerez, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berrueta</LastName><ForeName>Julen</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0009-1015-9780</Identifier><AffiliationInfo><Affiliation>Critical Care Department, Hospital Universitari Joan XXIII, 43005 Tarragona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tarragona Health Data Research Working Group (THeDaR), 43005 Tarragona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>García-Martínez</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Critical Care Department, Hospital Universitari Joan XXIII, 43005 Tarragona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tarragona Health Data Research Working Group (THeDaR), 43005 Tarragona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suberviola</LastName><ForeName>Borja</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Critical Care Department, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guardiola</LastName><ForeName>Juan J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Robley Rex VA Medical Center, University of Louisville, Louisville, KY 40202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bodí</LastName><ForeName>María</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7652-8379</Identifier><AffiliationInfo><Affiliation>Critical Care Department, Hospital Universitari Joan XXIII, 43005 Tarragona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Universitat Rovira &amp; Virgili, 43005 Tarragona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pere Virgili Health Research Institute, 43005 Tarragona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>GETGAG/COVID-19 SEMICYUC Working Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>FBC02/2023</GrantID><Agency>Barri Casanovas Private Foundation Scholarship</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Antibiotics (Basel)</MedlineTA><NlmUniqueID>101637404</NlmUniqueID><ISSNLinking>2079-6382</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">bacterial coinfection</Keyword><Keyword MajorTopicYN="N">fungal coinfection</Keyword><Keyword MajorTopicYN="N">influenza A (H1N1)</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>9</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39452234</ArticleId><ArticleId IdType="pmc">PMC11504409</ArticleId><ArticleId IdType="doi">10.3390/antibiotics13100968</ArticleId><ArticleId IdType="pii">antibiotics13100968</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Simonsen L., Spreeuwenberg P., Lustig R., Taylor R.J., Fleming D.M., Kroneman M., Van Kerkhove M.D., Mounts A.W., Paget W.J., the GLaMOR Collaborating Teams Global Mortality Estimates for the 2009 Influenza Pandemic from the GLaMOR Project: A Modeling Study. PLoS Med. 2013;10:e1001558. doi: 10.1371/journal.pmed.1001558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001558</ArticleId><ArticleId IdType="pmc">PMC3841239</ArticleId><ArticleId IdType="pubmed">24302890</ArticleId></ArticleIdList></Reference><Reference><Citation>Viboud C., Simonsen L. Global mortality of 2009 pandemic influenza A H1N1. Lancet Infect. Dis. 2012;9:651–653. doi: 10.1016/S1473-3099(12)70152-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(12)70152-4</ArticleId><ArticleId IdType="pubmed">22738892</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathieu E., Ritchie H., Rodés-Guirao L., Appel C., Giattino C., Hasell J., Macdonald B., Dattani S., Beltekian D., Ortiz-Ospina E., et al.  “Coronavirus Pandemic (COVID-19)”. 2020 Published online at OurWorldInData.org.  [(accessed on 3 August 2024)].  Available online:  https://ourworldindata.org/coronavirus.</Citation></Reference><Reference><Citation>World Health Organization  2023 Data.who.int. WHO Coronavirus (COVID-19) Dashboard &gt; Deaths [Dashboard]  [(accessed on 13 August 2024)].  Available online:  https://data.who.int/dashboards/covid19/deaths.</Citation></Reference><Reference><Citation>Martin-Loeches I., Schultz M.J., Vincent J.-L., Alvarez-Lerma F., Bos L.D., Solé-Violán J., Torres A., Rodriguez A. Increased incidence of co-infection in critically ill patients with influenza. Intensive Care Med. 2017;43:48–58. doi: 10.1007/s00134-016-4578-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4578-y</ArticleId><ArticleId IdType="pubmed">27709265</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodríguez A.H., Avilés-Jurado F.X., Díaz E., Schuetz P., Trefler S.I., Solé-Violán J., Cordero L., Vidaur L., Estella Á., Socias L., et al. Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: A CHAID decision-tree analysis. J. Infect. 2016;72:143–151. doi: 10.1016/j.jinf.2015.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2015.11.007</ArticleId><ArticleId IdType="pubmed">26702737</ArticleId></ArticleIdList></Reference><Reference><Citation>Carbonell R., Urgelés S., Rodríguez A., Bodí M., Martín-Loeches I., Solé-Violán J., Díaz E., Gómez J., Trefler S., Vallverdú M., et al. Mortality comparison between the first and second/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: A multicentre retrospective cohort study. Lancet Reg. Health Eur. 2021;11:100243. doi: 10.1016/j.lanepe.2021.100243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100243</ArticleId><ArticleId IdType="pmc">PMC8566166</ArticleId><ArticleId IdType="pubmed">34751263</ArticleId></ArticleIdList></Reference><Reference><Citation>Langford B.J., So M., Raybardhan S., Leung V., Westwood D., MacFadden D.R., Soucy J.-P.R., Daneman N. Bacterial co-infection and secondary infection in patients with COVID-19: A living rapid review and meta-analysis. Clin. Microbiol. Infect. 2020;26:e1622–e1629. doi: 10.1016/j.cmi.2020.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.07.016</ArticleId><ArticleId IdType="pmc">PMC7832079</ArticleId><ArticleId IdType="pubmed">32711058</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodríguez A., Moreno G., Bodi M., Martín-Loeches I. Antibiotics in development for multiresistant gram-negative bacilli. Med. Intensiv. (Engl. Ed.) 2022;46:630–640. doi: 10.1016/j.medin.2022.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medin.2022.05.005</ArticleId><ArticleId IdType="pubmed">36302707</ArticleId></ArticleIdList></Reference><Reference><Citation>Kariyawasam R.M., Julien D.A., Jelinski D.C., Larose S.L., Rennert-May E., Conly J.M., Dingle T.C., Chen J.Z., Tyrrell G.J., Ronksley P.E., et al. Antimicrobial resistance (AMR) in COVID-19 patients: A systematic review and meta-analysis (November 2019–June 2021) Antimicrob. Resist. Infect. Control. 2022;11:45. doi: 10.1186/s13756-022-01085-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13756-022-01085-z</ArticleId><ArticleId IdType="pmc">PMC8899460</ArticleId><ArticleId IdType="pubmed">35255988</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawson T.M., Moore L.S.P., Zhu N., Ranganathan N., Skolimowska K., Gilchrist M., Satta G., Cooke G., Holmes A.H. Bacterial and Fungal Coinfection in Individuals with Coronavirus: A Rapid Review to Support COVID-19 Antimicrobial Prescribing. Clin. Infect. Dis. 2020;71:2459–2468. doi: 10.1093/cid/ciaa530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa530</ArticleId><ArticleId IdType="pmc">PMC7197596</ArticleId><ArticleId IdType="pubmed">32358954</ArticleId></ArticleIdList></Reference><Reference><Citation>Varshney K., Pillay P., Mustafa A.D., Shen D., Jenna Renee Adalbert J.R., Mahmood M.Q. A systematic review of the clinical characteristics of influenza-COVID-19 co-infection. Clin. Exp. Med. 2023;23:3265–3275. doi: 10.1007/s10238-023-01116-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-023-01116-y</ArticleId><ArticleId IdType="pmc">PMC10618381</ArticleId><ArticleId IdType="pubmed">37326928</ArticleId></ArticleIdList></Reference><Reference><Citation>Delhommeau G., Buetti N., Neuville M., Siami S., Cohen Y., Laurent V., Mourvillier B., Reignier J., Goldgran-Toledano D., Schwebel C., et al. Bacterial Pulmonary Co-Infections on ICU Admission: Comparison in Patients with SARS-CoV-2 and Influenza Acute Respiratory Failure: A Multicentre Cohort Study. Biomedicines. 2022;10:2646. doi: 10.3390/biomedicines10102646.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10102646</ArticleId><ArticleId IdType="pmc">PMC9599916</ArticleId><ArticleId IdType="pubmed">36289906</ArticleId></ArticleIdList></Reference><Reference><Citation>Patton M.J., Orihuela C.J., Harrod K.S., Bhuiyan M.A.N., Dominic P., Kevil C.G., Fort D., Liu V.X., Farhat M., Koff J.L., et al. COVID-19 bacteremic co-infection is a major risk factor for mortality, ICU admission, and mechanical ventilation. Crit. Care. 2023;27:34. doi: 10.1186/s13054-023-04312-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-023-04312-0</ArticleId><ArticleId IdType="pmc">PMC9868503</ArticleId><ArticleId IdType="pubmed">36691080</ArticleId></ArticleIdList></Reference><Reference><Citation>Carbonell R., Moreno G., Martín-Loeches I., Bodí M., Rodríguez A. The Role of Biomarkers in Influenza and COVID-19 Community-Acquired Pneumonia in Adults. Antibiotics. 2023;12:161. doi: 10.3390/antibiotics12010161.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics12010161</ArticleId><ArticleId IdType="pmc">PMC9854478</ArticleId><ArticleId IdType="pubmed">36671362</ArticleId></ArticleIdList></Reference><Reference><Citation>Carbonell R., Moreno G., Martín-Loeches I., Gomez-Bertomeu F., Sarvisé C., Gómez J., Bodí M., Díaz E., Papiol E., Trefler S., et al. Prognostic Value of Procalcitonin and C-Reactive Protein in 1608 Critically Ill Patients with Severe Influenza Pneumonia. Antibiotics. 2021;10:350. doi: 10.3390/antibiotics10040350.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics10040350</ArticleId><ArticleId IdType="pmc">PMC8066504</ArticleId><ArticleId IdType="pubmed">33810263</ArticleId></ArticleIdList></Reference><Reference><Citation>Carbonell R., Urgelés S., Salgado M., Rodríguez A., Reyes L.F., Fuentes Y.V., Serrano C.C., Caceres E.L., Bodí M., Martín-Loeches I., et al. Negative predictive value of procalcitonin to rule out bacterial respiratory co-infection in critical COVID-19 patients. J. Infect. 2022;85:374–381. doi: 10.1016/j.jinf.2022.06.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.06.024</ArticleId><ArticleId IdType="pmc">PMC9245395</ArticleId><ArticleId IdType="pubmed">35781017</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu F., Jia Y., Zhao D., Fu X., Zhang W., Tang W., Hu S., Wu H., Ge M., Du W., et al. Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: Systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019-positive patients. Clin. Microbiol. Infect. 2023;29:835–844. doi: 10.1016/j.cmi.2023.03.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2023.03.017</ArticleId><ArticleId IdType="pmc">PMC10023211</ArticleId><ArticleId IdType="pubmed">36934872</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami Y., Nozaki Y., Morosawa M., Toyama M., Ogashiwa H., Ueda T., Nakajima K., Tanaka R., Takesue Y. Difference in the impact of coinfections and secondary infections on antibiotic use in patients hospitalized with COVID-19 between the Omicron-dominant period and the pre-Omicron period. J. Infect. Chemother. 2024;30:853–859. doi: 10.1016/j.jiac.2024.02.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiac.2024.02.026</ArticleId><ArticleId IdType="pubmed">38428674</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham M.S., Sudre C.H., May A., Antonelli M., Murray B., Varsavsky T., Kläser K., Canas L.S., Molteni E., Modat M., et al. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: An ecological study. Lancet Public Health. 2021;6:e335–e345. doi: 10.1016/S2468-2667(21)00055-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(21)00055-4</ArticleId><ArticleId IdType="pmc">PMC8041365</ArticleId><ArticleId IdType="pubmed">33857453</ArticleId></ArticleIdList></Reference><Reference><Citation>For the Efraim investigators and the Nine-I study group. Martin-Loeches I., Lemiale V., Geoghegan P., McMahon M.A., Pickkers P., Soares M., Perner A., Meyhoff T.S., Bukan R.B., et al. Influenza and associated co-infections in critically ill immunosuppressed patients. Crit. Care. 2019;23:152. doi: 10.1186/s13054-019-2425-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2425-6</ArticleId><ArticleId IdType="pmc">PMC6498695</ArticleId><ArticleId IdType="pubmed">31046842</ArticleId></ArticleIdList></Reference><Reference><Citation>Corey L., Beyrer C., Cohen M.S., Michael N.L., Bedford T., Rolland M. SARS-CoV-2 Variants in Patients with Immunosuppression. N. Engl. J. Med. 2021;385:562–566. doi: 10.1056/NEJMsb2104756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsb2104756</ArticleId><ArticleId IdType="pmc">PMC8494465</ArticleId><ArticleId IdType="pubmed">34347959</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans R.A., Dube S., Lu Y., Yates M., Arnetorp S., Barnes E., Bell S., Carty L., Evans K., Graham S., et al. Impact of COVID-19 on immunocompromised populations during the Omicron era: Insights from the observational population-based INFORM study. Lancet Reg. Health—Eur. 2023;35:100747. doi: 10.1016/j.lanepe.2023.100747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2023.100747</ArticleId><ArticleId IdType="pmc">PMC10730312</ArticleId><ArticleId IdType="pubmed">38115964</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliva I., Ferré C., Daniel X., Cartanyà M., Villavicencio C., Salgado M., Vidaur L., Papiol E., de Molina F.G., Bodí M., et al. Risk factors and outcome of acute kidney injury in critically ill patients with SARS-CoV-2 pneumonia: A multicenter study. Med. Intensiv. (Engl. Ed.) 2024 doi: 10.1016/j.medine.2024.06.022. in press .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medine.2024.06.022</ArticleId><ArticleId IdType="pubmed">39003118</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodríguez A., Ruiz-Botella M., Martín-Loeches I., Herrera M.J., Solé-Violan J., Gómez J., Bodí M., Trefler S., Papiol E., Díaz E., et al. Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in Spain. Crit. Care. 2021;25:63. doi: 10.1186/s13054-021-03487-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03487-8</ArticleId><ArticleId IdType="pmc">PMC7883885</ArticleId><ArticleId IdType="pubmed">33588914</ArticleId></ArticleIdList></Reference><Reference><Citation>Uyeki T.M., Bernstein H.H., Bradley J.S., Englund J.A., File T.M., Jr., Fry A.M., Gravenstein S., Hayden F.G., Harper S.A., Hirshon J.M., et al. Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza. Clin. Infect. Dis. 2019;68:e1–e47. doi: 10.1093/cid/ciy866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciy866</ArticleId><ArticleId IdType="pmc">PMC6653685</ArticleId><ArticleId IdType="pubmed">30566567</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  Clinical Management of Severe Acute Respiratory Infection (SARI) When COVID-19 Disease is Suspected: Interim Guidance. 13 March 2020.  [(accessed on 13 August 2024)].  Available online:  https://iris.who.int/bitstream/handle/10665/331446/WHO-2019-nCoV-clinical-2020.4-eng.pdf?sequence=1&amp;isAllowed=y.</Citation></Reference><Reference><Citation>Verweij P.E., Rijnders B.J.A., Brüggemann R.J.M., Azoulay E., Bassetti M., Blot S., Calandra T., Clancy C.J., Cornely O.A., Chiller T., et al. Review of influenza-associated PA in ICU patients and proposal for a case definition: An expert opinion. Intensive Care Med. 2020;46:1524–1535. doi: 10.1007/s00134-020-06091-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06091-6</ArticleId><ArticleId IdType="pmc">PMC7306567</ArticleId><ArticleId IdType="pubmed">32572532</ArticleId></ArticleIdList></Reference><Reference><Citation>Claverias L., Daniel X., Martín-Loeches I., Vidal-Cortez P., Gómez-Bertomeu F., Trefler S., Zaragoza R., Borges-Sa M., Reyes L.F., Quindós G., et al. Impact of Aspergillus spp. isolation in the first 24 hours of admission in critically ill patients with severe influenza virus pneumonia. Med. Intensiv. 2022;46:426–435. doi: 10.1016/j.medin.2021.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medin.2021.12.005</ArticleId><ArticleId IdType="pubmed">35868719</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunardon N., Menardi G., Torelli N. ROSE: A Package for Binary Imbalanced Learning.  [(accessed on 10 August 2024)];R J. 2014 6:79–89. doi: 10.32614/RJ-2014-008. Available online:  https://journal.r-project.org/archive/2014-1/menardi-lunardon-torelli.pdf.</Citation><ArticleIdList><ArticleId IdType="doi">10.32614/RJ-2014-008</ArticleId></ArticleIdList></Reference><Reference><Citation>Menardi G., Torelli N. Training and assessing classification rules with imbalanced data. Data Min. Knowl. Discov. 2014;28:92–122. doi: 10.1007/s10618-012-0295-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10618-012-0295-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramsey J.B. Tests for Specification Errors in Classical Linear Least-Squares Regression Analysis. J. R. Stat. Soc. Ser. B (Methodol.) 1969;21:350–371. doi: 10.1111/j.2517-6161.1969.tb00796.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2517-6161.1969.tb00796.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai C.C., Chen S.Y., Ko W.C., Hsueh P.R. Increased antimicrobial resistance during the COVID-19 pandemic. Int. J. Antimicrob. Agents. 2021;57:106324. doi: 10.1016/j.ijantimicag.2021.106324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2021.106324</ArticleId><ArticleId IdType="pmc">PMC7972869</ArticleId><ArticleId IdType="pubmed">33746045</ArticleId></ArticleIdList></Reference><Reference><Citation>Su L., Yu T., Zhang C., Huo P., Zhao Z. A prediction model for secondary invasive fungal infection among severe SARS-CoV-2 positive patients in ICU. Front. Cell. Infect. Microbiol. 2024;14:1382720. doi: 10.3389/fcimb.2024.1382720.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2024.1382720</ArticleId><ArticleId IdType="pmc">PMC11260608</ArticleId><ArticleId IdType="pubmed">39040601</ArticleId></ArticleIdList></Reference><Reference><Citation>van Grootveld R., van der Beek M.T., Janssen N.A., Ergün M., van Dijk K., Bethlehem C., Stads S., van Paassen J., Heunks L.M., Bouman C.S., et al. Incidence, risk factors and pre-emptive screening for COVID-19 associated pulmonary aspergillosis in an era of immunomodulant therapy. J. Crit. Care. 2023;76:154272. doi: 10.1016/j.jcrc.2023.154272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2023.154272</ArticleId><ArticleId IdType="pmc">PMC9934852</ArticleId><ArticleId IdType="pubmed">36801598</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Li W., Wang H., Song P. Development and validation of machine learning-based models for predicting healthcare-associated bacterial/fungal infections among COVID-19 inpatients: A retrospective cohort study. Antimicrob. Resist. Infect. Control. 2024;13:42. doi: 10.1186/s13756-024-01392-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13756-024-01392-7</ArticleId><ArticleId IdType="pmc">PMC11017584</ArticleId><ArticleId IdType="pubmed">38616284</ArticleId></ArticleIdList></Reference><Reference><Citation>López-Herrero R., Prada L.S.-D., Tamayo-Velasco A., Lorenzo-López M., Gómez-Pesquera E., Sánchez-Quirós B., de la Varga-Martínez O., Gómez-Sánchez E., Resino S., Tamayo E., et al. Epidemiology of bacterial co-infections and risk factors in COVID-19-hospitalized patients in Spain: A nationwide study. Eur. J. Public Health. 2023;33:675–681. doi: 10.1093/eurpub/ckad060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurpub/ckad060</ArticleId><ArticleId IdType="pmc">PMC10393489</ArticleId><ArticleId IdType="pubmed">37087109</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu R.B.H., Zhao S., Zhang J.Z., Chan K.C.K., Ng P.Y., Chan C., Fong K.M., Au S.Y., Yeung A.W.T., Chan J.K.H., et al. Comparison of COVID-19 with influenza A in the ICU: A territory-wide, retrospective, propensity matched cohort on mortality and length of stay. BMJ Open. 2023;13:e067101. doi: 10.1136/bmjopen-2022-067101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-067101</ArticleId><ArticleId IdType="pmc">PMC10335442</ArticleId><ArticleId IdType="pubmed">37429680</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannella M., Rinaldi M., Tesini G., Gallo M., Cipriani V., Vatamanu O., Campoli C., Toschi A., Ferraro G., Horna C.S., et al. Predictive model for bacterial co-infection in patients hospitalized for COVID-19: A multicenter observational cohort study. Infection. 2022;50:1243–1253. doi: 10.1007/s15010-022-01801-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01801-2</ArticleId><ArticleId IdType="pmc">PMC9053127</ArticleId><ArticleId IdType="pubmed">35488112</ArticleId></ArticleIdList></Reference><Reference><Citation>Masiá M., Padilla S., Antequera P., Ramos J.M., Ruiz M., Gutiérrez F. Predictors of Pneumococcal Co-infection for Patients with Pandemic (H1N1) 2009. Emerg. Infect. Dis. 2011;17:1475–1478. doi: 10.3201/eid1708.101673.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1708.101673</ArticleId><ArticleId IdType="pmc">PMC3381536</ArticleId><ArticleId IdType="pubmed">21801627</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>